Disease Modifying
TZIELD — Sanofi PAP (Uninsured)
Who it is for
Uninsured or underinsured patients with Stage 2 or Stage 3 T1D diagnosis
What it covers
Free or reduced-cost teplizumab course; COMPASS team navigates entire process
What it costs you
No fee to apply. Your out-of-pocket cost depends on the coverage above.
Eligibility
- Uninsured or underinsured patients with Stage 2 or Stage 3 T1D diagnosis
- Insurance status: uninsured
- Diabetes type: T1D
- U.S. residency or citizenship documentation required
- Available in: all